Dan Lu

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

Sandhya Girish, Manish Gupta, Bei Wang et al. · Cancer Chemotherapy and Pharmacology · 2012 · 265 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity

Dan Lu, Haifan Zhang, Henry Koo et al. · Journal of Biological Chemistry · 2005 · 180 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Guide to Rational Dosing of Monoclonal Antibodies

Shuang Bai, Karin Jorga, Denise Jin et al. · Clinical Pharmacokinetics · 2012 · 163 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species

Kefang Liu, Xiaoqian Pan, Linjie Li et al. · Cell · 2021 · 154 citations · Full text

Life Sciences, Biology, Molecular Biology +12

Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody

Dan Lu, Haifan Zhang, Dale L. Ludwig et al. · Journal of Biological Chemistry · 2004 · 125 citations · Full text

Pharmacy, Oncology, Pharmacology +17